Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Decadron — HEXADROL
Application NDA012674 (NDA)
Decadron — DECADERM
Application NDA013538 (NDA)
Decadron — DECADRON
Application NDA012071 (NDA)
Decadron — DECADRON-LA
Application NDA016675 (NDA)
Decadron — DEXACORT
Application NDA013413 (NDA)
Decadron — DECADRON
Application NDA011977 (NDA)
Decadron — DECADRON
Application NDA011984 (NDA)
Decadron — MAXIDEX
Application NDA013422 (NDA)
Decadron — DECADRON
Application NDA011664 (NDA)
Decadron — HEXADROL
Application NDA012675 (NDA)
Decadron — HEXADROL
Application NDA014694 (NDA)
Decadron — DEXACORT
Application NDA014242 (NDA)
Decadron — DECASPRAY
Application NDA012731 (NDA)
Decadron — DECADRON
Application NDA011983 (NDA)
Decadron — DECADRON
Application NDA012376 (NDA)
Orgaran — ORGARAN
Application NDA020430 (NDA)
Decadron — OZURDEX
Application NDA022315 (NDA)
Decadron — DEXTENZA
Application NDA208742 (NDA)
Decadron — DEXYCU KIT
Application NDA208912 (NDA)
Decadron — HEMADY
Application NDA211379 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)